The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy

Abstract Purpose The residual cancer burden index (RCB) was proposed as a response evaluation criterion in breast cancer patients treated with Neoadjuvant Chemotherapy (NAC). This study evaluated the relevance of RCB with replase-free survival (RFS). Methods The clinical data of 254 breast cancer pa...

Descripción completa

Detalles Bibliográficos

Autores principales:	Xin Xu, Wei Zhao, Cuicui Liu, Yongsheng Gao, Dawei Chen, Meng Wu, Chao Li, Xinzhao Wang, Xiang Song, Jinming Yu, Zhaoyun Liu, Zhiyong Yu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2024-01-01
Colección:	BMC Cancer
Materias:	Residual cancer burden Neoadjuvant chemotherapy Breast cancer Pathologic complete response Miller-Payne grading
Acceso en línea:	https://doi.org/10.1186/s12885-023-11719-z
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!